• 제목/요약/키워드: Neuroprotective agents

검색결과 53건 처리시간 0.022초

귀비탕(歸脾湯)의 농도별(濃度別) 구강투여(口腔投與)가 백서(白鼠)의 허혈성(虛血性) 뇌손상(腦損傷)에 미치는 영향(影響) (The Dose-dependent Effects of Guibi-Tang on Focal Brain Ischemic Injury in Rats)

  • 국윤재;박장호;김진형;김향이;강형원;류영수
    • 동의신경정신과학회지
    • /
    • 제22권4호
    • /
    • pp.201-218
    • /
    • 2011
  • Objectives : The aim of this study was to investigate the effects of Guibi-Tang(GBT) on focal brain ischemic injury induced by intraluminal filament insertion in rats. Methods : The ischemia was induced by intraluminal filament insertion into middle cerebral artery. Sprague-Dawley rats were divided into five groups, normal group(n=8); control group was ischemia induced and no treatment(n=8); GBT 1X group was ischemia induced and administrated 42.2 mg/ml/kg of Guibi-Tang orally(n=8); GBT 3X group was ischemia induced and administrated 126.6 mg/ml/kg of Guibi-Tang orally(n=8); GBT 6X group was ischemia induced and administrated 253.2 mg/ml/kg of Guibi-Tang orally(n=8) for 21 days. mGluR5, Bax, Bcl-2 and cytochrome C were investigated to observe the effects of Guibi-Tang on apoptosis. The effects of Guibi-Tang on neuroprotective/apoptotic agents in cresyl violet, choline acetyltranferase(ChAT) with ischemic injury were investigated. Results : The intensity of mGluR5 mRNA in the hippocampal CA1 was increased in normal and GBT(Guibi-Tang) 1X groups compared with the control group. The intensity of Bax mRNA in the hippocampal CA1 was decreased in normal and GBT 1X groups compared with the control group. However it was increased unexpectedly in GBT 3X group. The intensity of Bcl-2 mRNA in the hippocampal CA1 was increased in normal and GBT 1X groups compared with the control group. The intensity of Bax/Bcl-2 ratio in the hippocampal CA1 was decreased in normal and GBT 1X groups compared with the control group. The intensity of cytochrome C protein in the hippocampal CA1 was decreased in normal, GBT 1X and GBT 6X groups compared with the control group. The density of neurons stained by cresyl violet and ChAT was increased in normal and GBT 1X groups compared with the control group. Conclusions : These results suggest that Guibi-Tang may have protective effect on vascular dementia.

녹차 theanine을 이용한 젤리 제조 및 품질특성 조사 (Production of green tea jelly using theanine and its physiochemical characterization)

  • 김성경;정하나;임애은;양광열;최용수;남승희
    • 한국식품과학회지
    • /
    • 제53권5호
    • /
    • pp.553-560
    • /
    • 2021
  • 본 연구에서는 저온진공조건에서 추출 시간과 농도에 따른 녹차 열수추출조건을 최적화한 후 HP-20 column으로 caffeine을 제거한 녹차 추출물을 이용해 theanine 함유 기능성 젤리를 제조하였다. 또한, theanine 함유 젤리의 품질 특성, 제형안정성 및 항산화 효과, AChE 억제능을 조사하였다. 최적추출조건은 8% 녹차 분말을 2시간 추출하여 theanine 0.95 mg/mL, GABA 0.28 mg/mL, caffeine 1.45 mg/mL 추출액을 HP-20 column을 이용해 80% 에탄올로 카페인을 제거하였다. 3종의 겔화제와 농도별로 4종의 theanine 추출물 S1-S4(10-50%)을 제조해 품질 특성을 조사한 결과, 젤리에 theanine 추출물이 많을수록 L값과 b값이 증가하였다. 젤리의 물리적 특성을 조사한 결과, 3가지 겔화제 중 타마린드검, 잔탄검, 로거스트콩검(2:3:5=w/w/w)을 조합한 겔화제 III이 경도와 점착성이 낮고 탄력성이 높아 조직감이 가장 뛰어났다. 제형안정성 조사 시, 35%가 첨가된 S3가 이수율 25.88%과 붕괴율 1.31%로 우수한 제형안정성을 나타냈다. 또한 theanine 함유 젤리는 95℃, 30분간 가열조건에도 theanine과 GABA 성분이 파괴되지 않고 대부분 잔존하는 것을 TLC와 LC-MS 분석을 통해 확인했다. Theanine 추출물의 농도가 높을수록 DPPH radical 소거능은 증가하며, S4(50%)는 0.075 mg/mL ascorbic acid 수준과 유사한 항산화력을 나타냈다. AChE 저해 효과는 S3(35%)가 가장 높았으며 이는 donepezil 2.5 μM과 동일한 수준의 AChE 저해 활성을 나타냈다. 따라서 본 연구는 녹차 추출물에서 caffeine을 제거한 theanine 추출물로 기능성 젤리를 제조하였으며 품질 특성을 조사하였다.

항암제 유발 신경독성을 관리하는 한의학 및 보완대체요법들과 임상시험 현황 (The Present Clinical Studies of Oriental Medicine and CAM Therapies in Chemotherapy-induced Peripheral Neurotoxicity)

  • 박선주;고호연;한유진;고성규;김성훈
    • 대한본초학회지
    • /
    • 제24권4호
    • /
    • pp.205-213
    • /
    • 2009
  • Objectives : Cancer incidence is increasing in all countries and chemotherapy-induced peripheral neuropathy (CIPN) in patients undergoing chemotherapeutic agents have been a clinically serious problems. So far therapeutic options for CIPN patients are limited and no confirmed methods have yet been established for dealing with peripheral neuropathy. Therefore this review is to provide an evidence-based summary of oriental medicine and CAM (complementary and alternative medicine) neuroprotective and treatment therapies which have gone through clinical trials. Methods : An overview of the domestic and international papers of adult clinical trials relating management of only CIPN symptoms through 1990 to present were searched by electronic databases. Search key words were chemotherapy-induced neurotoxicity, chemotherapy-induced peripheral neuropathy, chemotherapy toxicity & herb, chemotherapy toxicity & acupuncture, chemotherapy toxicity & CAM. Only English and Korean written papers were reviewed. Total 25 papers were reviewed in this study, 18 papers were retrieved by electronic search. Results : Clinical studies of managing CIPN were rare, two acupuncture clinical studies and four herb medicinal studies were found. Rest of 19 papers were about other CAM clinical studies. Total 25 papers were analyzed, and all interventions were focused on their pain control efficacy. Other 24 trials of potential therapies except one proved to be effective for CIPN, however some described to be inadequate positive or sufficient negative. Conclusions : As most of the studies were pilot studies, interventions for the prevention and treatment of CIPN have to go through prospective confirmatory studies, such as larger scale randomized, double-blinded, placebo controlled clinical trials must be done for the safe and effective use of proposed therapies. Also standard measurement scales have to be developed for the better clinical study of CIPN.